. 2002 Sep 16;3(9):806–812. doi: 10.1093/embo-reports/kvf187

Table I. New genome projects (completed or in progress) and Gates Foundation-funded orphan drug and vaccine initiatives for developing countries.

Infectious disease	Genome project	Genomics funding	Drug	Vaccine initiative	Amount ($ million)
African trypanosomiasis	TIGR/Sanger	NIAID/Beowolf	Drug development	University of North Carolina	15
		Children’s Vaccine Fund		GAVI (Geneva)	750
Cholera/Typhoid/Shigella	TIGR/Sanger/University of Wisconsin	NIAID/Wellcome		International Vaccine Institute (Seoul)	40
HIV/AIDS				International AIDS Vaccine Initiative	125
Hookworm	Washington University/Sanger	NIAID/Beowolf	Hookworm Vaccine	Sabin Institute	18
Leishmaniasis	SBRI/Sanger	Beowolf/EC/NIAID	Leishmaniasis Vaccine	IDRI	15
Lymphatic filariasis	Sanger/Smith College	Beowolf/NIAID	Drug control	World Bank	20
Malaria	TIGR/NMRI/Sanger	NIAID/BWF/Wellcome	Malaria Vaccine Initiative	PATH	50
	SAIC		Malaria Vaccine	NIH	40
				London School of Hygiene & Tropical Medicine	40
Measles			Improved vaccine	Johns Hopkins University/UMD	20
Meningococcal meningitis	TIGR/Sanger	Chiron/Wellcome	Meningitis Vaccine	PATH–WHO	70
Trachoma	TIGR	NIAID	Drug control	International Trachoma Initiative	20
Tuberculosis	Sanger/TIGR	Wellcome/NIAID	TB Vaccine Initiative	Sequella	25
	MDR	TB	Control	Harvard	45
		TB Diagnosis Initiative/TDR		WHO	10